Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumococcal vaccines.

J D Campbell1, M B Rennels

  • 1Department of Pediatrics, Division of Infectious Diseases and Tropical Pediatrics, University of Maryland, Baltimore 21201-1505, USA.

Drugs of Today (Barcelona, Spain : 1998)
|September 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epithelial miR-149-5p up-regulation is associated with immune evasion in progressive bronchial premalignant lesions.

bioRxiv : the preprint server for biology·2025
Same author

Allergen-specific T cell responses to immunotherapy monitored by CD154 and intracellular cytokine expression.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2010
Same author

Medicolegal role in tests.

Canadian Medical Association journal·2010
Same author

The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective.

Allergy·2010
Same author

Rotational laxity greater in patients with contralateral anterior cruciate ligament injury than healthy volunteers.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2009
Same author

Health economics of asthma: assessing the value of asthma interventions.

Allergy·2008

Streptococcus pneumoniae (pneumococcus) remains a significant cause of disease and death. Improved vaccination strategies, including new conjugate vaccines for infants, are crucial for prevention.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Vaccinology

Background:

  • Streptococcus pneumoniae causes substantial disease and mortality globally.
  • Current polysaccharide vaccines offer moderate protection but are underutilized, leading to preventable deaths.

Purpose of the Study:

  • To highlight the ongoing burden of pneumococcal disease.
  • To emphasize the need for improved vaccination coverage in adults and children.
  • To introduce the development of conjugate vaccines for infants.

Main Methods:

  • Review of existing data on pneumococcal disease burden and vaccine efficacy.
  • Analysis of vaccination coverage and its impact on mortality.
  • Discussion of advancements in vaccine technology.

Related Experiment Videos

Main Results:

  • An estimated 40,000 deaths occur annually in U.S. adults due to pneumococcus.
  • Nearly half of these deaths could be prevented with adherence to current vaccination recommendations.
  • Conjugate vaccines demonstrate safety, immunogenicity, and efficacy against invasive pneumococcal disease in infants.

Conclusions:

  • Enhanced efforts in education, delivery, and financing are needed to improve vaccine uptake in older children and adults.
  • Conjugate vaccines represent a major advancement in preventing invasive pneumococcal disease in infants.
  • Continued research and implementation are vital to reduce the global burden of pneumococcal infections.